Deebo Samuel says he's "Not struggling at all just not getting the ball"
New York Giants rookie wide receiver Malik Nabers doesn't regret blowing his top following a Week 12 loss to the Tampa Bay Buccaneers. On Sunday, Nabers told the media the Giants looked "soft" in the 30-7 blowout and not all their issues tie to the quarterback . New York released QB Daniel Jones after benching him for Tommy DeVito. In his Tuesday news conference, Nabers said he talked with general manager Joe Schoen and head coach Brian Daboll about his comments. He added he should've used different verbiage but isn't backtracking. "So, yeah, if I had an opportunity to go back and change the words I said, I would," Nabers said. "But I still stand on what I said. I said it. I don't have no regrets with what I said. But like I said, as I look at it on the film, we just lacked technique." "If I had an opportunity to go back and change the words that I said, I would. I still stand on what I said. I said it. I don't have no regrets with what I said." - Malik Nabers pic.twitter.com/vNGAY3M5fs Nabers also admitted he was frustrated about his involvement in the offense. Pro Football Talk's Myles Simmons noted Nabers had no targets in the first half against Tampa Bay but finished with six receptions for 64 yards. "Like I said, when I look at it, we tried to get me the ball a couple times in the first half — just had a lack of communication," Nabers said. "We just [were] out of sorts as an offense. So, we only had, I think, 15 plays in the first half. They had 40-something. So, it's not a lot of plays you can get when you call 15 plays in the half." In his Monday news conference , Daboll said he must do "a better job of getting the ball in [Nabers'] hands early." The coach said they're still on good terms as well. Still, Nabers' comments could signal Daboll is losing control of the Giants locker room after falling to 2-9. Monitor whether New York's play improves in Thursday's road game against the Dallas Cowboys (4-7) and if Nabers receives more targets in the first half.Retiring Manchester Salvation Army major leaves a legacy of hopeSacramento Kings part ways with head coach Mike Brown, source saysNone
After a resounding 4-0 win over Yeovil Town on Saturday, York dropped to a disappointing defeat against Altrincham with Regan Linney scoring a brace, added to by Matty Kosylo. All three goals of the match came in the first-half, with Hinshelwood frustrated by City’s display in the opening 45 minutes and felt that any form of response from his side came far too late in the contest. “It was a bit different from last year, but could have been the same after the lad lobbed Rory,” Hinshelwood admitted. “You can’t play with grit and determination when you’re 3-0 down, run about and get close to people. “When you’re 3-0 down, you can’t give a response, it needs to be there every time you step foot out because the National League is unforgiving. “You have to be prepared to outwork the opponent Saturday, Tuesday, Saturday, Tuesday. “That’s why I made the changes today, I wanted to keep it fresh and they haven’t worked. “They’ve got to take full responsibility for that. “A really disappointing night, more so for the fans again because they come out in full force. “It’s a difficult place to get to on a Tuesday night and over 700 deserves more than what we’ve given them. “I’m really disappointed with the first-half, but I thought that we had a real go in the second-half and the goalkeeper made some unbelievable saves. “We stuck to a bit more of a game plan in the second-half and maybe my team selection was way off today. “We started the game well, took some corners and pinned them back for the first ten minutes. “But then you can’t have spells in the National League where you sort of switch off and get played around for half an hour, that’s what can happen. “I thought that we probably didn’t get to grips with their set-up quick enough to play through them and identify where the spaces were for us. “When they got the ball they were sharper, won more duels than us and you just can’t win a game if that’s going to happen. “It happened for a large part of the first-half.” Hinshelwood also felt that Kosylo’s strike, which was Altrincham’s third, killed the match for York with any signs of a comeback unlikely against difficult opposition. He also berated his players for not taking responsibility in possession, and not dealing with the pressure that Altrincham applied as City failed to break down the Robins. Hinshelwood added: “The last one killed us, coming in 3-0. 2-0 gives you a little bit more hope maybe, but the third one was just so soft. “It’s hunger from them to press and a bad decision from us, we didn’t quite execute it and it’s players not taking responsibility. “They put us under pressure and the players didn’t want to pass it back or be on the ball, the easy one is to play back to the goalie it seems. “We played that a lot, and it’s another team that has come and let Callum Howe have the ball and we’ve struggled when that’s been the case. “You have got to give credit to the opposition, I thought that they were sharper and when it mattered, they were more clinical. “If you looked at the amount the ball was in the final third today, it would be even, if not, we had more. “Their forwards have come up with the bits of magic at the right times.”
ANDOVER, Mass. , Nov. 26, 2024 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced that it will host an Investor & Analyst Day in New York City on Tuesday, December 10, 2024 , at 10:00 AM ET . Waleed Hassanein , MD., President and Chief Executive Officer, and members of the leadership team will present an overview of TransMedics' growth strategy, clinical pipeline, and operations. A live and archived webcast of presentations and Q&A sessions will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com . Please note management will only take questions from the live audience during the question-and-answer session following the formal presentations. In-person attendance at the event requires advanced registration. Please email Laine Morgan at laine@gilmartinir.com by December 4, 2024 , for further information. About TransMedics Group, Inc. TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts , the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure. Investor Contact: Brian Johnston Laine Morgan 332-895-3222 Investors@transmedics.com View original content to download multimedia: https://www.prnewswire.com/news-releases/transmedics-to-host-investor--analyst-day-on-december-10-2024-302316931.html SOURCE TransMedics Group, Inc.VALPARAISO, Ind. (AP) — Valparaiso hired longtime Marietta coach Andy Waddle as its new football coach, athletic director Laurel Hosmer announced Monday. Waddle is scheduled to be formally introduced on campus Wednesday. He spent the last 12 seasons turning around the Division III program located in Southeastern Ohio. There, he went 55-61 after inheriting a winless team. He led the Pioneers to their first 8-0 start last season and matched the 1920 squad's school record with a 13-game winning streak that started in 2023. In 2024, Marietta made its first postseason appearance since 1973. Waddle went 16-5 over the past two seasons and produced seven winning records over the last eight seasons. The Pioneers had only two winning seasons in the previous 20 years. “I think there is a great group of young men on the (Valparaiso) roster, and we’re excited to invest in those student-athletes and continue to add more high-quality people and football players to the program,” Waddle said of the program located in Indiana's northwest corner. “I think Valpo is not only an outstanding fit for me professionally, but also an outstanding fit for me and my family.” Waddle spent eight seasons working with the defense as an assistant for his alma mater, Wittenberg, where he was an all-conference defensive back. He also has coached at Mansfield University in Pennsylvania and at Maryville College in Tennessee. “His experience building success and winning culture as a head coach, passion for developing student-athletes on and off the field and high character made it clear he was the right leader for our football program,” Hosmer said in a statement. The move comes two weeks after Hosmer announced the school would not give Landon Fox a contract extension after his deal expired. Fox was 21-42 in six seasons at Valparaiso. Get poll alerts and updates on the AP Top 25 throughout the season. Sign up here . AP college football: https://apnews.com/hub/ap-top-25-college-football-poll and https://apnews.com/hub/college-football
Shares of Bristol Myers Squibb ($BMY) were in the spotlight on Friday after the U.S. Food and Drug Administration approved an injectable version of the pharmaceutical major’s cancer drug Opdivo. Opdivo is reportedly part of PD-1 inhibitors class of drugs, known to aid the immune system's cancer-fighting abilities, Reuters reported. A total of 495 patients were randomized to receive either “subcutaneous nivolumab and hyaluronidase-nvhy or intravenous nivolumab,” according to a FDA statement on the approval. The approval includes indications for renal cell carcinoma; melanoma; non-small cell lung cancer; head and neck squamous cell carcinoma; colorectal cancer, hepatocellular carcinoma, esophageal carcinoma, gastric cancer; and esophageal adenocarcinoma, among other cancers. Opdivo Qvantig is not indicated in combination with intravenous ipilimumab, the statement added. Following the news, retail sentiment on Stocktwits turned ‘extremely bullish’. Message volumes improved to ‘normal’. Earlier this week, Bristol Myers also updated on results from its POETYK PsA-1 and POETYK PsA-2, the pivotal Phase 3 trials examining the efficacy and safety of Sotyktu in adults with active psoriatic arthritis. Both trials met their primary endpoint, with a significantly greater proportion of Sotyktu-treated patients achieving ACR20 response after 16 weeks of treatment compared with placebo, the company said. Bristol Myers is due to report its fourth quarter of 2024 on Thursday, February 6. BMY stock is up 9% year-to-date. For updates and corrections, email newsroom[at]stocktwits[dot]com.